A Heterologous Prime-boost Study to Evaluate Immunogenicity and Safety of mRNA-1273 With MVC-COV1901 in Adults

Clinical trial NCT05079633 · COMPLETED

Trial details

NCT number: NCT05079633
Sponsor: National Taiwan University Hospital
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Covid19 Vaccine

Start date: 2021-09-30
Primary completion: 2021-10-08
Enrollment: 220

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.